» Articles » PMID: 1726319

Selective Activation of Quisqualate Metabotropic Receptor Potentiates NMDA but Not AMPA Responses

Overview
Journal Eur J Pharmacol
Specialty Pharmacology
Date 1991 Dec 3
PMID 1726319
Citations 25
Authors
Affiliations
Soon will be listed here.
Citing Articles

Allosteric Modulators of Metabotropic Glutamate Receptors as Novel Therapeutics for Neuropsychiatric Disease.

Luessen D, Conn P Pharmacol Rev. 2022; 74(3):630-661.

PMID: 35710132 PMC: 9553119. DOI: 10.1124/pharmrev.121.000540.


Modulation of NMDA Receptors by G-protein-coupled receptors: Role in Synaptic Transmission, Plasticity and Beyond.

Lutzu S, Castillo P Neuroscience. 2020; 456:27-42.

PMID: 32105741 PMC: 9359616. DOI: 10.1016/j.neuroscience.2020.02.019.


Targeting metabotropic glutamate receptors for novel treatments of schizophrenia.

Maksymetz J, Moran S, Conn P Mol Brain. 2017; 10(1):15.

PMID: 28446243 PMC: 5405554. DOI: 10.1186/s13041-017-0293-z.


Development of 1-Pyrazolo[3,4-]pyridines as Metabotropic Glutamate Receptor 5 Positive Allosteric Modulators.

Hill M, Fang H, Brown J, Molski T, Easton A, Han X ACS Med Chem Lett. 2016; 7(12):1082-1086.

PMID: 27994742 PMC: 5150689. DOI: 10.1021/acsmedchemlett.6b00292.


Modulation of excitatory neurotransmission by neuronal/glial signalling molecules: interplay between purinergic and glutamatergic systems.

Koles L, Kato E, Hanuska A, Zadori Z, Al-Khrasani M, Zelles T Purinergic Signal. 2015; 12(1):1-24.

PMID: 26542977 PMC: 4749532. DOI: 10.1007/s11302-015-9480-5.